ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
2.42
0.04 (1.68%)
At close: Jun 27, 2025, 3:59 PM
2.47
1.85%
After-hours: Jun 27, 2025, 05:54 PM EDT
1.68% (1D)
| Bid | 2.41 |
| Market Cap | 5.79M |
| Revenue (ttm) | 8.01M |
| Net Income (ttm) | -7.13M |
| EPS (ttm) | 264.12 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.48 |
| Volume | 426,213 |
| Avg. Volume (20D) | 3,097,830 |
| Open | 2.36 |
| Previous Close | 2.38 |
| Day's Range | 2.36 - 2.59 |
| 52-Week Range | 2.23 - 414.70 |
| Beta | 1.94 |
About RSLS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RSLS
Website n/a
3 days ago
-6.11%
RSLS stock has given up its prior gain. ReShape Li...
Unlock content with
Pro Subscription
3 days ago
-6.11%
ReShape Lifesciences shares are trading higher after the company announced it was granted an institutional patent from the Australian Patent Office for its Diabetes Neuromodulation technology.
